Thursday, September 25, 2014

A $56.5. Million Settlement for Adderall False Claims - NYT

The Justice Department said on Wednesday that the European drug maker Shire had agreed to pay $56.5 million to settle accusations of making false claims in the marketing of its attention deficit disorder drug Adderall XR and other medicines. The settlement involved charges that Shire, from January 2004 to December 2007, promoted its extended release Adderall with claims of superiority over rival medicines that were not supported by clinical data. The company was also accused of promoting the drug for unapproved uses and of making other false claims not supported by data, like that Adderall XR would prevent poor academic performance, loss of employment, criminal behavior, traffic accidents and sexually transmitted disease. The company said it had not admitted any wrongdoing in connection with the settlement.

No comments: